Bring more to life.
Are you ready to accelerate your potential and make a real difference within life sciences, diagnostics and biotechnology?
At Radiometer, one of Danaher’s 15+ operating companies, our work saves lives—and we’re all united by a shared commitment to innovate for tangible impact.
You’ll thrive in a culture of belonging where you and your unique viewpoint matter. And by harnessing Danaher’s system of continuous improvement, you help turn ideas into impact – innovating at the speed of life. At Radiometer, life comes first. Our vision is to improve global healthcare with reliable, fast, and easy patient diagnoses. We’re a team that celebrates diverse ideas and continuous improvement. Here, you’ll find a place to grow and make a real impact, with your unique perspective driving us forward in improving patient care.
Learn about the Danaher Business System which makes everything possible.
The Director Strategic Portfolio & innovation Management, is responsible for leading the development and execution of a long-term innovation roadmap to address unmet clinical needs in acute care diagnostics. This strategic role ensures alignment between cross-functional priorities and long-range portfolio investments to improve patient care and support business growth.
The position reports to the Senior Director, Product & Portfolio Management and is part of the Product & Portfolio Management team. The role is ideally located in Copenhagen, Denmark or based elsewhere in Europe with regular presence in Copenhagen.
In this role, you will have the opportunity to:
- Develop and maintain a 5-year innovation roadmap aligned with strategic goals and clinical needs.
- Identify, map, and prioritize unmet needs across care settings and disease clusters through customer and market insights.
- Build and evaluate strategic business cases to support portfolio decisions and investment priorities.
- Lead cross-functional teams through early innovation processes including concept feasibility, target product profiles, and launch planning.
- Define and implement standard processes for portfolio governance, new product development (NPD), and launch excellence.
- Collaborate with R&D, Commercial, Medical Affairs, Market Access, and Regulatory Affairs to translate strategy into executable plans.
- Support strategic partnerships, licensing, and M&A assessments in collaboration with Business Development and Market Intelligence.
The essential requirements of the job include:
- Long-standing experience in healthcare innovation, strategy, or portfolio management, preferably within diagnostics or medical devices.
- Advanced degree in Business, Life Sciences, Engineering, or a related field (e.g., MBA, PhD, or MD).
- Strong analytical and commercial acumen with experience building business cases and defining product strategies.
- Experience leading cross-functional teams in a matrix environment.
- Fluent in English, both written and spoken.
Travel requirements:
- Ability to travel internationally up to 25%.
- Role requires presence at Radiometer HQ in Copenhagen on a regular basis.
It would be a plus if you also possess previous experience in:
- The in-vitro diagnostics (IVD) industry or medical technology sector.
- Strategy consulting, corporate innovation, or business development.
Radiometer, a Danaher operating company, offers a broad array of comprehensive, competitive benefit programs that add value to our lives. Whether it’s a health care program or paid time off, our programs contribute to life beyond the job. Check out our benefits at Danaher Benefits Info.
Join our winning team today. Together, we’ll accelerate the real-life impact of tomorrow’s science and technology. We partner with customers across the globe to help them solve their most complex challenges, architecting solutions that bring the power of science to life.
For more information, visit www.danaher.com.
At Danaher, we value diversity and the existence of similarities and differences, both visible and not, found in our workforce, workplace and throughout the markets we serve. Our associates, customers and shareholders contribute unique and different perspectives as a result of these diverse attributes.
